{"id":"NCT01363440","sponsor":"Regeneron Pharmaceuticals","briefTitle":"Study of Intravitreal Aflibercept Injection (IAI; EYLEA®; BAY86-5321) in Patients With Diabetic Macular Edema","officialTitle":"A Double-Masked, Randomized, Active-Controlled, Phase 3 Study of the Efficacy and Safety of Intravitreal Administration of VEGF Trap-Eye in Patients With Diabetic Macular Edema","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2011-05","primaryCompletion":"2013-01","completion":"2014-11","firstPosted":"2011-06-01","resultsPosted":"2015-04-20","lastUpdate":"2016-05-30"},"enrollment":466,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"TRIPLE","primaryPurpose":"TREATMENT"},"conditions":["Diabetic Macular Edema"],"interventions":[{"type":"DRUG","name":"Intravitreal Aflibercept Injection (IAI; EYLEA®; BAY86-5321)","otherNames":[]},{"type":"PROCEDURE","name":"Macular Laser Photocoagulation","otherNames":[]}],"arms":[{"label":"Macular Laser Photocoagulation Treatment (Control)","type":"ACTIVE_COMPARATOR"},{"label":"Intravitreal Aflibercept Injection (IAI;EYLEA®;BAY86-5321) 2Q4","type":"EXPERIMENTAL"},{"label":"Intravitreal Aflibercept Injection (IAI;EYLEA®;BAY86-5321) 2Q8","type":"EXPERIMENTAL"}],"summary":"The purpose of this study is to determine the efficacy of Intravitreal Aflibercept Injection (IAI; EYLEA®; BAY86-5321) on the best corrected visual acuity (BCVA) assessed by the early treatment diabetic retinopathy study (ETDRS) chart in patients with diabetic macular edema (DME) with central involvement.","primaryOutcome":{"measure":"Change From Baseline in Best Corrected Visual Acuity (BCVA) as Measured by Early Treatment Diabetic Retinopathy Study (ETDRS) Letter Score at Week 52 - Last Observation Carried Forward (LOCF)","timeFrame":"Baseline and Week 52","effectByArm":[{"arm":"Control","deltaMin":0.1,"sd":1.03},{"arm":"Intravitreal Aflibercept Injection (IAI;EYLEA®;BAY86-5321) 2Q4","deltaMin":12.3,"sd":0.76},{"arm":"Intravitreal Aflibercept Injection (IAI;EYLEA®;BAY86-5321) 2Q8","deltaMin":10.6,"sd":0.69}],"pValues":[{"comp":"OG000 vs OG001","p":"<.0001"},{"comp":"OG000 vs OG002","p":"<.0001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":51,"countries":["United States"]},"refs":{"pmids":["36265076","35440699","30946887","29785301","29051325","28006063","27847634"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":67,"n":154},"commonTop":["Conjunctival haemorrhage","Hypertension","Conjunctival haemorrhage","Urinary tract infection","Diabetic retinal oedema"]}}